Skip to main content
PLOS One logoLink to PLOS One
. 2024 Sep 20;19(9):e0310769. doi: 10.1371/journal.pone.0310769

Additional predictors of stroke and transient ischaemic attack in BEFAST positive patients in out-of-hours emergency primary care

Florien S van Royen 1,*, Geert-Jan Geersing 1, Daphne C Erkelens 1, Mathé Delissen 1, Jorn V F Rutten 1, Dorien L Zwart 1, Maarten van Smeden 2,3, Frans H Rutten 1, Sander van Doorn 1
Editor: Shashank Shekhar4
PMCID: PMC11414940  PMID: 39302942

Abstract

Introduction

In patients suspected of stroke or transient ischemic attack (TIA), rapid triaging is imperative to improve clinical outcomes. For this purpose, balance-eye-face-arm-speech-time (BEFAST) items are used in out-of-hours primary care (OHS-PC). We explored the risk of stroke and TIA among BEFAST positive patients calling to the OHS-PC, and assessed whether additional predictors could improve risk stratification.

Methods

This is a cross-sectional study of retrospectively gathered routine care data from telephone triage tape-recordings of patients calling the OHS-PC with neurological deficit symptoms, classified as BEFAST positive. Four models–with the predictors age, sex, a history of cardiovascular or cerebrovascular disease, and cardiovascular risk factors–were fitted using logistic regression to predict the outcome stroke or TIA. Likelihood ratio testing was used to select the best model, which was subsequently internally validated.

Results

The risk of stroke or TIA diagnosis was 52% among 1,289 BEFAST positive patients, median age 72 years, 56% female sex. Of patients with the outcome stroke/TIA, 24% received a low urgency allocation, while 92% had signs or symptoms when calling. Only the addition of age and sex improved predicting stroke or TIA (internally validated c-statistic 0.72, 95%CI 0.69–0.75). The predicted risk of stroke or TIA remained below 20% in those aged below 40. Females aged 70 or over and males aged 55 or over, had a predicted risk above 50%.

Discussion

Urgency allocation appears to be suboptimal in BEFAST positive patients calling the OHS-PC. Risk stratification could be improved in this setting by adding age and sex.

Introduction

Stroke and transient ischemic attack (TIA) are life-threatening medical emergencies that require rapid action to reduce morbidity and mortality. Nonetheless, early recognition remains difficult as stroke/TIA present themselves with many non-specific and often ambiguous symptoms. Moreover, there are important mimicking disorders such as migraine with aura, seizures, metabolic and toxic disorders, peripheral vestibular disease, Bell’s palsy, collapse, and functional disorders [13]. In the Netherlands, many patients with such yet undefined symptoms will contact primary care first. During out-of-hours, this happens to be telephonically with the out-of-hours services in primary care (OHS-PCs) [4]. On the phone, patients are first assisted by a triage nurse supervised by a general practitioner (GP). The triage nurse assesses the urgency of the symptoms based on triage questions from the Netherlands Triage Standard (NTS), which is a semi-automatic decision support tool [5]. This allocation of urgency through triaging is a balancing act between safety and efficiency. Telephone triage needs to be safe enough to avoid missing cases of stroke/TIA (good sensitivity), while also being efficient enough by not unnecessarily assigning high urgency to low-risk patients that may overwhelm already strained healthcare utilisation during out-of-hours primary care (good specificity). Hence, triaging remains a difficult and challenging process [6].

The FAST items (face, arm, speech, time), later updated to BEFAST (adding balance and eye to FAST), were developed as diagnostic tools to create awareness about warning signs suggestive of stroke or TIA [7, 8]. The BEFAST items are mainly used and validated in the prehospital setting (ambulance dispatch centers and OHS-PC) and the emergency department of the hospital [9]. While these items are part of one of the 56 ‘entrance complaints’ of the NTS, namely ‘neurologic deficit’, it is yet unclear what the implications are of using BEFAST items for the estimation of stroke/TIA risk through telephone triage in the primary care emergency setting [5].

This study describes the risk of stroke/TIA in callers to the OHS-PC with symptoms suggestive of neurological deficit and consequently classified as BEFAST positive. Furthermore, it aims to explore other simple clinical predictors to be used during telephone triage in BEFAST positive patients that can further aid in distinguishing between patients that have a higher risk of a diagnosis of stroke or TIA from those with a lower risk of having these diagnoses.

Methods

Study design and setting

This is a cross-sectional study using retrospective data from telephone triage tape-recordings of patients calling to the OHS-PC. In these facilities, triage nurses and GPs provide out-of-hours emergency primary care for all Dutch citizens. Data from nine OHS-PC locations in the central region of the Netherlands were used that provide out-of-hours care to 1.5 million inhabitants with 300,000 calls on average per year. This is a post-hoc analysis of the Safety First study and its design has been described in more detail elsewhere [10]. Data were accessed from April 25 until November 17 2023. Where applicable, this study adhered to the TRIPOD checklist for prediction modelling studies [11].

Study population

Between January 1 2014 and December 31 2017, a random sample of 2,500 recorded calls was selected for analysis. Patients with symptoms suggestive of stroke or TIA were identified based on a search of International Classification of Primary Care (ICPC) codes and/or keywords in the electronic healthcare records (EHR) of the OHS-PCs. Exclusion criteria for this study were age below 18, callers living outside OHS-PC area (final diagnosis not possible to retrieve), poor quality of recording and non-triage calls [10]. BEFAST classification was done after data collection. Those having at least one item scored as positive were considered ‘BEFAST positive’, and only BEFAST positive patients were included for further analyses. All ICPC codes and keywords used for inclusion and definitions of BEFAST items are provided in S1 Table.

Data collection

Data were collected from the OHS-PC EHR and from telephone triage tape-recordings. Patient demographics and call characteristics were retrieved from the EHR and BEFAST items, medical history and final urgency allocation were collected from the phone tape-recordings. There are five urgency categories used by the OHS-PCs: U1 (ambulance dispatch within 15 min), U2 (GP consultation (home visit or at the OHS-PC) within one hour), U3 (GP consultation within three hours), U4 (GP consultation within 24 hours) and U5 (self-care telephone advice). All data were collected by trained researchers and medical students while blinded for the outcome.

Outcome

The primary outcome of this study was a final diagnosis of stroke or TIA diagnosed by a neurologist or GP, the first with neuroimaging and the latter based on neurological deficit symptoms only. During triage and based upon urgency allocation, either an ambulance was sent, a home visit or consultation at the OHS-PC was offered, or the patient was advised to contact their own GP the next working day. Therefore, following clinical practice, the diagnostic work-up differed between patients. To ensure similar assessment of outcome for all patients, the final diagnosis was confirmed by the patient’s own GP through discharge letters and medical record screening up to one month after the date of calling to the OHS-PC.

Data analysis

Descriptive statistics were used for baseline characteristics. Categorical variables were summarised as numbers with percentages and continuous variables were summarised as means with standard deviations or medians with interquartile ranges. To identify additional predictors of stroke and TIA among BEFAST positive callers to the OHS-PC, four multivariable logistic regression models were fitted and compared by likelihood ratio tests (alpha of 0.05 for significance). A fixed modelling approach was used with predefined predictors based on literature and clinical experience. Model one consisted of the predictors age and sex. Model two additionally included a combined predictor for history of cardio- and/or cerebrovascular disease. Model three consisted of a combined predictor for cardiovascular risk factors including hypertension, diabetes and/or hypercholesterolaemia, in addition to age and sex. The fourth model included all predictors (age, sex, disease history of cardio- and cerebrovascular disease and cardiovascular risk factors). Age was handled as a continuous variable and a restricted cubic spline with four knots on the percentiles 0.05, 0.35, 0.65 and 0.95 was applied to account for non-linearity. Additionally, an interaction term was added to age and sex [12]. Sex was handled as a categorical variable with two categories (biologically male and female) and all other predictors were also handled as categorical variables with two categories (e.g. history of cardio- and cerebrovascular disease being present or absent). To correct for optimism in the model’s estimates, the best model was internally validated using bootstrapping with 100 repetitions after which the area under the curve (AUC/c-statistic), R2 and slope were calculated. Statistical analyses were performed in R version 4.2.2 with R base, rms, mice and pROC packages [1316].

Sample size considerations

For sample size calculation, the method by Riley et al. for logistic regression modelling was used [17]. For prediction model development, 1,289 BEFAST positive patients were available with an outcome rate of 0.52 for the combined outcome of stroke and TIA. A c-statistic of 0.70 was chosen for sample size calculation which was based on the c-statistic reported in a similar study validating a TIA recognition tool in primary care [18]. The sample size of 1,289 patients was calculated to be large enough to include up to a maximum of 18 candidate predictors. This was sufficient to include the prespecified predictors as described above, restricted cubic spline for age with four knots and an interaction term for age and sex.

Missing data

Missing data for BEFAST items were not imputed because of the complexity of data structure, i.e. the presence of BEFAST items is dependent on ordered questions and answers on previous triage questions. Hence, we assumed missing data on BEFAST to follow a MNAR (missing not at random) pattern. It is widely acknowledged that in such circumstances it is preferred to refrain from imputation of these items [19]. Missing data for candidate predictors were assumed to be MAR (missing at random) and were imputed using multiple imputation by chained equation methods included in the ‘mice’ package in R. A random forests method was used, and 100 datasets were generated with 20 iterations [13, 20]. The percentage of missing data per predictor is shown in S2 Table.

Ethical approval

This study was conducted in accordance with Dutch law, the European Union General Data Protection Regulation (GDPR) and the principles of the Declaration of Helsinki. It is part of the larger Safety First study (National Trial Register identification number: NTR7331) [10]. The Medical Ethics Review Committee Utrecht, the Netherlands, reviewed the study and formal approval was waived as minimal patient participation was required. During data collection from telephone recordings, data were pseudonymised for further analyses conform the GDPR.

Results

Population

From the random sample of 2,500 recorded calls that were selected based on the inclusion criteria, 1,381 could be used for final analyses. The other 1,119 calls were excluded based on exclusion criteria or because the outcome could not be retrieved due to nonresponse or refusal of the enlisted GP. Details on patient flow through the study are depicted in S1 Fig. After data collection, 1,289 patients were classified as BEFAST positive. There were 92 patients for whom BEFAST could not be determined because of missing data, and these patients were excluded from further analyses.

Patient characteristics

Characteristics of all BEFAST positive patients are shown in Table 1. Median age was 72 years, 56% were female and 92% still had symptoms during the call to the OHS-PC. In 52% of stroke or TIA was diagnosed; 17% stroke and 35% TIA or minor stroke. These patients were generally older (median 79 years versus median 64 years), more often had a history of cardiovascular disease and had more cardiovascular risk factors (hypertension, hypercholesterolaemia and diabetes) than those without stroke or TIA. 24% of BEFAST positive patients with stroke or TIA received a low urgency allocation during triage (U3, U4 or U5), these patients had similar demographic characteristics (median age 80 versus 79 years and 58% versus 55% female sex), more often had a personal history of TIA (37% versus 32%) and less often had a personal history of stroke (23% versus 28%) than patients that were correctly allocated to high urgency (U1 and U2). A neurologist diagnosed stroke or TIA in 83% of the cases based on clinical symptoms plus neuroimaging, and 17% (mainly older patients) was diagnosed by GPs based on clinical symptoms.

Table 1. Patient characteristics of all BEFAST positive patients.

Patient characteristic BEFAST positive patients (n = 1,289) Outcome no stroke/TIA (n = 617, 48%) Outcome stroke/TIA (n = 672, 52%)
Age in years (IQR) 72 (58–86) 64 (47–78) 79 (68–86)
Female sex 728 (56%) 355 (58%) 373 (56%)
History of TIA 182 (28%, n = 658) 62 (21%, n = 297) 120 (33%, n = 361)
History of stroke 175 (27%, n = 658) 78 (26%, n = 297) 97 (27%, n = 361)
History of CVD 685 (77%, n = 889) 279 (68%, n = 409) 409 (85%, n = 483)
History of CAD 55 (18%, n = 310) 26 (15%, n = 174) 29 (21%, n = 136)
History of arrythmia 60 (26%, n = 299) 22 (13%, n = 167) 38 (29%, n = 132)
Heart failure 24 (9%, n = 269) 8 (5%, n = 155) 16 (14%, n = 114)
Hypertension 212 (49%, n = 430) 86 (38%, n = 224) 126 (61%, n = 206)
Hypercholesterolaemia 167 (42%, n = 400) 62 (31%, n = 202) 105 (53%, n = 198)
Diabetes 149 (35%, n = 424) 62 (28%, n = 226) 87 (44%, n = 198)
Acute onset of symptoms 64 (30%, n = 212) 32 (29%, n = 111) 32 (32%, n = 101)
Symptoms still present at time of calling 1185 (92%) 573 (93%) 612 (91%)
U1 urgency 316 (25%) 126 (20%) 190 (28%)
U2 urgency 591 (46%) 268 (43%) 323 (48%)
Low urgency (U3, U4 or U5) 385 (30%) 223 (36%) 159 (24%)
Referred to neurologist 878 (69%, n = 1275) 323 (53%, n = 609) 555 (83%, n = 666)
Final diagnosis TIA/minor stroke 455 (68%)
Final diagnosis major stroke 217 (32%)

BEFAST = balance eye face arm speech time; CAD = cardiac artery disease; CVD = cardiovascular disease; IQR = interquartile range; TIA = transient ischaemic attack; U = urgency

Predictors of stroke and TIA in BEFAST positive patients

All 1,289 BEFAST positive patients were used to develop the four prespecified models. When compared by likelihood ratio test, in our dataset, model 2, 3 and 4 (including the added predictors history of cardio- and cerebrovascular disease and cardiovascular risk factors) did not prove to perform significantly better than model 1 only including age and sex, as shown in Table 2. The regression coefficients with confidence intervals, the apparent performance and internal validation performance of model 1 are shown in Table 3. Regression coefficients with confidence intervals and apparent performance of model 2, model 3 and model 4 are provided in S3 Table. The apparent c-statistic of model 1 was 0.73 (95% CI 0.70–0.75) and the internally validated c-statistic was 0.72 (95%CI 0.69–0.75). In Fig 1, the predicted risks of stroke and TIA predicted by model 1 are plotted for age, and male and female sex. Overall, predicted risk increased with age and was higher for male patients at mid-life than for female patients at mid-life. For instance, until the age of 40, the predicted risk for both female and male patients remained below 20%. A risk of >50% was reached for female patients from the age of about 70, while for male patients this was reached from the age of about 55.

Table 2. Comparison of the four models.

Model 1 versus model 2 Model 1 versus model 3 Model 1 versus model 4
ΔAUC 0.001 0.001 0.001
Likelihood ratio test 0.933, df = 1, p = 0.334 0.448, df = 1, p = 0.503 0.413, df = 2, p = 0.662

ΔAUC and likelihood ratio test comparing model 2 (including the predictor history of cardio- and cerebrovascular disease), model 3 (including the predictor cardiovascular risk factors) and model 4 (including both the predictors history of cardio- and cerebrovascular disease and cardiovascular risk factors) with model 1 (including only the predictors age and sex). ΔAUC is calculated by taking the differences between the two models unadjusted c-statistics.

Table 3. Model development and internal validation of model 1 using multivariable logistic regression.

Predictor Regression coefficient 95% CI
Intercept -5.993 -8.526; -3.459
Age 0.115 0.063; 0.167
Age’ -0.111 -0.185; -0.036
Age” 0.690 0.128; 1.252
Female sex 2.255 -0.823; 5.333
Interaction sex and age -0.063 -0.128; 0.001
Interaction sex and age’ 0.114 0.020; 0.208
Interaction sex and age” -0.634 -1.356; 0.078
Performance measures
Apparent c-statistic 0.73 0.70; 0.75
R 2 cs 0.22
Internal validation c-statistic 0.72 0.69; 0.75
Internal validation R 2 0.21
Internal validation slope 0.96

Regression coefficients with 95% confidence intervals, c-statistic, and internal validation performance measures of the best model (model 1) including the predictors age, sex and the interaction between age and sex. Age was divided into three subgroups (shown as age, age’ and age”) using restricted cubic spline function to account for non-linearity. CI = confidence interval; R2cs = R2 Cox-Snell.

Fig 1. Predicted risk of stroke and TIA.

Fig 1

Plot of predicted risk of stroke and TIA in BEFAST positive patients shown for men and women at different ages. Confidence intervals are shown in grey.

Discussion

This study showed that patients calling to the OHS-PC with symptoms suggestive of stroke or TIA, and at least one item of BEFAST positive, had a high risk (52%) of having a final diagnosis of stroke or TIA. Of these stroke/TIA patients, 76% received a high urgency allocation. Only sex and age could improve triaging while a history of cardio- and cerebrovascular disease, or cardiovascular risk factors (hypertension, diabetes or hypercholesterolaemia) could not further aid in predicting stroke/TIA in this high-risk patient group.

Comparison with existing literature

In the prehospital setting, such as the OHS-PC, where patients with possible stroke/TIA often present early-on in the disease course, it is pivotal to differentiate life-threatening conditions, such as stroke/TIA, from more benign conditions and mimics such as migraine with aura. During initial telephone triage, an accurate definitive diagnose may not yet be necessary, but accurate urgency allocation of patients at (high) risk of stroke or TIA is crucial. Therefore, any triaging tool needs a sufficiently high sensitivity (i.e. not missing any cases) while a high specificity is needed for efficiency. A Cochrane review from 2019 assessed the diagnostic accuracy of the FAST items and identified three studies reporting a sensitivity in the prehospital setting ranging from 0.64 to 0.97, however, with a broad range in specificity from 0.13 to 0.75 [9]. The addition of balance disturbance (B) and eye problems (E) to FAST is supposed to prevent missing stroke or TIA of the posterior cerebral circulation and thus increase sensitivity, however adding items to FAST will certainly further decrease specificity and thus efficiency [8]. By design, we selected patients that were all classified as BEFAST positive in our study sample, therefore, it was not feasible to calculate sensitivity and specificity for the BEFAST triaging tool.

Currently, there are many stroke and TIA prediction models and diagnostic tools available, mainly to be used at the emergency department or to detect large vessel occlusions to direct intervention [9, 21, 22]. Almost all these tools use similar items to BEFAST (i.e. signs and symptoms) to assess the probability of stroke or TIA, lacking possible additional predictors such as age, sex, cardio-cerebrovascular history and cardiovascular risk factors. In our study, sex and age provided additive predictive information in a BEFAST positive population while a history of cardio- or cerebrovascular disease, or cardiovascular risk factors (hypertension, diabetes or hypercholesterolaemia) did not add predictive information beyond signs and symptoms of BEFAST. Apparently, in a population already selected for their signs and symptoms and therefore with a high a priori risk of a stroke/TIA diagnosis, other clinical factors besides adding age and sex, will not further increase the ability to distinguish between higher and lower risk. We also assessed ‘someone else calling the OHS-PC for the patient’ as a predictor for stroke or TIA, but this variable had no added value beyond the predictors age and sex (data not shown).

Strengths and limitations

The major strength of this research is the use of routine care data, reflecting real-world clinical practice. Furthermore, only readily available predictors were analysed, preventing the increase in workload of triage nurses and GPs. Formal external validation of the final prediction model should be conducted to confirm predictive performance over time in the Dutch OHS-PC setting or to prove its predictive performance in other settings.

Two limitations to this work must be discussed. First, the dataset had missing values, a common finding when using routine care data. Although imputations were carefully executed and only under the MAR assumptions, introduction of some bias cannot be fully ruled out. Importantly, BEFAST is only considered negative if none of the symptoms are present, which was in none of our patients (partly due to missing data). As a result, we could not calculate the sensitivity, specificity, and predictive values of BE-FAST. Therefore, our results should be interpreted with some caution, and studies repeating our analyses in new data are necessary to confirm our findings. Second, the outcome of stroke and TIA was not assessed similarly for all patients, since only the patients that were still considered to be at risk of stroke or TIA after GP consultation were referred to the neurologist for further diagnostic imaging (differential verification) [11]. However, it is unlikely that many stroke or TIA cases were missed as a consequence of this selective referral. To make it even more unlikely to miss cases of stroke or TIA and to assess the outcome for all patients in a similar way, the outcome was assessed through contacting the enlisted GPs up to one month after visiting the OHS-PC, which also encompasses, for instance, delayed discharge letters.

Clinical implications

This study adds to a better understanding of the distribution of risks among BEFAST positive patients (i.e. the patients suspected of stroke or TIA) at the triage stage. While 92% of BEFAST positive patients still had symptoms at the moment of calling and 52% eventually received a diagnosis of stroke or TIA, only 76% of patients with the outcome stroke/TIA received a high urgency allocation. Incorporating age and sex of the patient in the triage process may improve urgency allocation, e.g. upscaling the urgency for elderly patients (both sexes) and for middle-aged male patients. External validation studies (temporal as well as geographical) and implementation studies are needed to evaluate the generalizability and clinical impact of these findings. Moreover, additional strategies to improve urgency allocation in patients suspected of stroke or TIA may be considered. For instance, it has been shown that safety of telephone triage improved when triage nurses overruled the decision support system (NTS), and urgency allocation was adjusted, either or not after consultation of a GP [6]. Such strategies may be the key to sustainable, safe and efficient telephone triage.

Conclusion

For BEFAST positive patients calling to the OHS-PC, the risk of stroke or TIA was above 50%. Despite this high risk, one in four patients received a low urgency allocation. The addition of age and sex can improve risk stratification with higher risks observed in older and male patients.

Supporting information

S1 Fig. Patient flow through the study.

(TIF)

pone.0310769.s001.tif (439.5KB, tif)
S1 Table. ICPC codes, keywords and definition of BEFAST items used in this study.

ICPC = International Classification of Primary Care.

(DOCX)

pone.0310769.s002.docx (13.5KB, docx)
S2 Table. Percentage of missing data per predictor in BEFAST positive patients.

(DOCX)

pone.0310769.s003.docx (13.8KB, docx)
S3 Table. Model development and apparent performance of model 2, model 3 and model 4 using multivariable logistic regression.

Regression coefficients with 95% confidence intervals, c-statistic, and apparent performance measures of model 2, model 3 and model 4. Age was divided into three subgroups (shown as age, age’ and age”) using restricted cubic spline function to account for non-linearity. *The predictor history of cardio- and cerebrovascular disease is a combination of history of stroke, history of TIA and history of cardiovascular disease. **The predictor cardiovascular risk factors is a combination of diabetes, hypercholesterolaemia and hypertension. CI = confidence interval.

(DOCX)

pone.0310769.s004.docx (16KB, docx)

Acknowledgments

The authors thank the OHS-PC foundation ‘Primair Huisartsenposten’ and all medical students that contributed to data collection.

List of abbreviations

AUC

area under the curve

BEFAST

balance eye face arm speech time

CAD

cardiac artery disease

CI

confidence interval

CVD

cardiovascular disease

EHR

electronic healthcare record

FAST

face arm speech time

GDPR

General Data Protection Regulation

GP

general practitioner

ICPC

International Classification of Primary Care

IQR

interquartile range

MAR

missing at random

MNAR

missing not at random

NTS

Netherlands Triage Standard

OHS-PC

out-of-hours primary care

R2cs

R2 Cox-Snell

TIA

transient ischemic attack

U

urgency

Data Availability

Data cannot be shared publicly because there are ethical restrictions being placed upon the data. The data contain potentially identifying and sensitive patient information. Moreover, a third party was involved in providing the telephone triage recordings from which the data were collected. This third party did not agree to make the data publicly available. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. The data can also be requested by filling in the data request form from the University Medical Center Utrecht. The link is provided below. Research support staff from the division will review and consider the requests. https://preview.umcutrecht.nl/en/data-request-form-umc-utrecht.

Funding Statement

This study was funded by an unrestricted grant from ZonMw (grant number 10060012210005). The Safety First Study was supported by the Department of General Practice of the University Medical Center Utrecht, the foundation ‘Netherlands Triage Standard’ and the foundation ‘Stoffels-Hornstra’. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Zweifler RM. Initial Assessment and Triage of the Stroke Patient. Prog Cardiovasc Dis. 2017. May 1;59(6):527–33. doi: 10.1016/j.pcad.2017.04.004 [DOI] [PubMed] [Google Scholar]
  • 2.Buck B H., Akhtar N, Alrohimi A, Khan K, Shuaib A. Stroke mimics: incidence, aetiology, clinical features and treatment. Vol. 53, Annals of Medicine. Taylor and Francis Ltd.; 2021. p. 420–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pohl M, Hesszenberger D, Kapus K, Meszaros J, Feher A, Varadi I, et al. Ischemic stroke mimics: A comprehensive review. Vol. 93, Journal of Clinical Neuroscience. Churchill Livingstone; 2021. p. 174–82. [DOI] [PubMed] [Google Scholar]
  • 4.Giesen P, Smits M, Huibers L, Grol R, Wensing M. Quality of After-Hours Primary Care in the Netherlands: A Narrative Review [Internet]. 2011. Available from: https://annals.org doi: 10.7326/0003-4819-155-2-201107190-00006 [DOI] [PubMed] [Google Scholar]
  • 5.Netherlands Triage Standard, https://de-nts.nl/, accessed July 31 2023.
  • 6.Erkelens DC, Rutten FH, Wouters LT, Dolmans LS, de Groot E, Damoiseaux RA, et al. Accuracy of telephone triage in patients suspected of transient ischaemic attack or stroke: a cross-sectional study. BMC Fam Pract. 2020. Dec 1;21(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke. 2003. Jan 1;34(1):71–6. doi: 10.1161/01.str.0000044170.46643.5e [DOI] [PubMed] [Google Scholar]
  • 8.Aroor S, Singh R, Goldstein LB. BE-FAST (Balance, Eyes, Face, Arm, Speech, Time): Reducing the Proportion of Strokes Missed Using the FAST Mnemonic. Stroke. 2017. Feb 1;48(2):479–81. doi: 10.1161/STROKEAHA.116.015169 [DOI] [PubMed] [Google Scholar]
  • 9.Zhelev Z, Walker G, Henschke N, Fridhandler J, Yip S. Prehospital stroke scales as screening tools for early identification of stroke and transient ischemic attack. Cochrane Database of Systematic Reviews. 2019. Apr 9;2019(4). doi: 10.1002/14651858.CD011427.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Erkelens DCA, Wouters LTCM, Zwart DLM, Damoiseaux RAMJ, De Groot E, Hoes AW, et al. Optimisation of telephone triage of callers with symptoms suggestive of acute cardiovascular disease in out-of-hours primary care: Observational design of the Safety First study. BMJ Open. 2019. Jul 1;9(7). doi: 10.1136/bmjopen-2018-027477 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): Explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73. doi: 10.7326/M14-0698 [DOI] [PubMed] [Google Scholar]
  • 12.Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis. Springer. 2015. [Google Scholar]
  • 13.van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. J Stat Softw. 2011;45(3). [Google Scholar]
  • 14.Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/. 2020.
  • 15.Harrell Jr FE. rms: Regression Modeling Strategies. R package version 6.2–0. https://CRAN.R-project.org/package=rms. 2021.
  • 16.Xavier R, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. MC Bioinformatics. 2011;12:77. doi: 10.1186/1471-2105-12-77 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Riley RD, Ensor J, Snell KIE, Harrell FE, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. The BMJ [Internet]. 2020;368(March):1–12. Available from: http://dx.doi.org/doi:10.1136/bmj.m441 [DOI] [PubMed] [Google Scholar]
  • 18.Lasserson DS, Mant D, Hobbs FDR, Rothwell PM. Validation of a TIA recognition tool in primary and secondary care: Implications for generalizability. International Journal of Stroke. 2015. Jul 1;10(5):692–6. doi: 10.1111/ijs.12201 [DOI] [PubMed] [Google Scholar]
  • 19.Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol. 2006. Oct;59(10):1087–91. doi: 10.1016/j.jclinepi.2006.01.014 [DOI] [PubMed] [Google Scholar]
  • 20.Austin PC, White IR, Lee DS, van Buuren S. Missing Data in Clinical Research: A Tutorial on Multiple Imputation. Canadian Journal of Cardiology. 2021. Sep;37(9):1322–31. doi: 10.1016/j.cjca.2020.11.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Antipova D, Eadie L, MacAden A, Wilson P. Diagnostic accuracy of clinical tools for assessment of acute stroke: A systematic review. BMC Emerg Med. 2019. Sep 4;19(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Duvekot MHC, Venema E, Rozeman AD, Moudrous W, Vermeij FH, Biekart M, et al. Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study. Lancet Neurol. 2021. Mar 1;20(3):213–21. doi: 10.1016/S1474-4422(20)30439-7 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Shashank Shekhar

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

8 May 2024

PONE-D-23-43803Additional predictors of stroke and transient ischaemic attack in BEFAST positive patients in out-of-hours emergency primary carePLOS ONE

Dear Dr. van Royen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Most of the points raised by the reviewers are addressable.

Please submit your revised manuscript by Jun 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shashank Shekhar, MD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: "This study was funded by an unrestricted grant from ZonMw (grant number 10060012210005). The Safety First Study was supported by the Department of General Practice of the University Medical Center Utrecht, the foundation ‘Netherlands Triage Standard’ and the foundation ‘Stoffels-Hornstra’."

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. In the online submission form, you indicated that the datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In patients suspected of stroke or transient ischemic attack (TIA), rapid triaging is imperative to improve clinical outcomes. For this purpose, balance-eye-face- arm-speech-time (BEFAST) items are used in out-of-hours primary care (OHS-PC). In this study, the authors investigated the risk of stroke and TIA among BEFAST positive patients calling to the OHS-PC, and assessed whether additional predictors could improve risk stratification. They report that the risk stratification could be improved in this setting by adding age and sex.

Reviewer #2: This is an interesting cross-sectional study conducted in Netherlands evaluating the addition of age and sex as predictors of stroke/TIA in BE-FAST positive patients in a pre-hospital setting. Although the design of the study, methodology used, interpretation of results and conclusions drawn has been impressive; the following concerns/issues remain unaddressed:

1. Introduction, Line 78 - "Moreover, there are important mimicking disorders such as migraine with aura.(1–3)" Stroke mimics are not limited to migraine with aura only. Physicians also need to be consider other common stroke mimics like syncope, seizures, hypoglycemia, etc., as important differentials. Consider adding these things when talking about stroke mimics in this statement.

2. Study design, Line 105 - "cross-sectional study". As per the methodology discussed in the manuscript, this would qualify as a retrospective cross-sectional study specifically. Please correct.

3. Outcome, Line 134 - "The primary outcome of this study was a final diagnosis of stroke or TIA diagnosed by a neurologist or GP." Can the authors provide more details on how the diagnosis of stroke/TIA was established? Was it based on clinical symptoms, neuroimaging or both? Please modify as appropriate.

4. Results, line 207 - "35% TIA or minor stroke." How many of these were moderate or high risk TIA? Please include in the results.

5. Discussion, Line 281 - " By design, we selected patients that were all classified as BEFAST positive in our study sample, therefore, it was not feasible to calculate sensitivity and specificity for the BEFAST triaging tool." It would have been more useful to see the sensitivity and specificity of BE-FAST in this patient population and to draw a meaningful conclusion on the performance of BE-FAST scale as compared to some of the other numbers in prior literature. The authors had access to all the records of stroke/TIA diagnosis to begin with. Any particular reason as to why only BE-FAST positive patients were selected for this study which probably limited the ability to calculate sensitivity, specificity, PPV and NPV in this patient population? Please explain in the discussion or limitations subheading.

6. Conclusion - " The addition of age and sex can improve risk stratification with higher risks observed in older and male patients." The median age noted was almost similar between the low urgency and high urgency group (80 vs. 79 years). Yet, age was noted to be a significant predictor of stroke/TIA in BE-FAST positive patients. Please explain?

7. The authors did not discuss if addition of age and sex to BE-FAST based on the results of this single center study would be applicable to patients from another geographic location - South East Asia (higher prevalence of elderly population in general along with vascular risk factors, African American and hispanic population (earlier age of onset of stroke and higher prevalence of atherosclerosis)? Please discuss under implications of this study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Aurel Popa-Wagner

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Sep 20;19(9):e0310769. doi: 10.1371/journal.pone.0310769.r002

Author response to Decision Letter 0


30 Jul 2024

Shashank Shekhar, MD

Academic Editor

PLOS ONE

Dear Editor,

We are very grateful for the opportunity given to resubmit our manuscript entitled ‘Additional predictors of stroke and transient ischaemic attack in BEFAST positive patients in out-of-hours emergency primary care’. We thank the editor and reviewers for the useful suggestions which we incorporated in our revised manuscript. Please find below the point-by-point answers to the questions and the changes made in the revised manuscript, which are also marked as ‘track changes’.

We are looking forward to your response to our revised manuscript.

On behalf of the co-authors,

Kind regards,

Florien S. van Royen, MSc, GP trainee

Dept. General Practice & Nursing Science, Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, Utrecht, the Netherlands

Journal Requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

The manuscript has now been formatted according to the style requirements as requested by PLOS One.

2. Thank you for stating the following financial disclosure: "This study was funded by an unrestricted grant from ZonMw (grant number 10060012210005). The Safety First Study was supported by the Department of General Practice of the University Medical Center Utrecht, the foundation ‘Netherlands Triage Standard’ and the foundation ‘Stoffels-Hornstra’."

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

The proposed statement "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript" is correct and has been included in our cover letter.

3. In the online submission form, you indicated that the datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

We agree with PLOS that full data transparency is preferred to support scientific findings. However, the data agreement contract with the third-party providing access to the pseudonymized data supporting this study did not include any conditions for publishing the data open access. Our local Medical Ethics Review Committee also did not ask us to provide to publish our data on an open-access platform, nor did they provide conditions for this. Therefore, at present, it is not possible to ask the parties involved for permission in hindsight. Because our data are highly privacy-sensitive, including backed-up telephone conversations with patients, and because an opt-out procedure was used for data collection, it is currently not possible to permit the publication of our dataset. We hope that the editor understands our reasons for not being able to make the dataset publicly available. We are happy to further discuss this with the editor and we are open to suggestions to increase transparency regarding the data underlying our findings.

Review Comments to the Author

Reviewer #1: In patients suspected of stroke or transient ischemic attack (TIA), rapid triaging is imperative to improve clinical outcomes. For this purpose, balance-eye-face- arm-speech-time (BEFAST) items are used in out-of-hours primary care (OHS-PC). In this study, the authors investigated the risk of stroke and TIA among BEFAST positive patients calling to the OHS-PC, and assessed whether additional predictors could improve risk stratification. They report that the risk stratification could be improved in this setting by adding age and sex.

We thank the reviewer for appraisal of the main message of our study.

Reviewer #2: This is an interesting cross-sectional study conducted in Netherlands evaluating the addition of age and sex as predictors of stroke/TIA in BE-FAST positive patients in a pre-hospital setting. Although the design of the study, methodology used, interpretation of results and conclusions drawn has been impressive; the following concerns/issues remain unaddressed:

1.Introduction, Line 78 - "Moreover, there are important mimicking disorders such as migraine with aura.(1–3)" Stroke mimics are not limited to migraine with aura only. Physicians also need to be consider other common stroke mimics like syncope, seizures, hypoglycaemia, etc., as important differentials. Consider adding these things when talking about stroke mimics in this statement.

Answer:

Indeed, there are many stroke mimics. For clarifying reasons, we added more examples of common stroke mimics to this statement, see below.

Changes to the manuscript:

This statement now reads: ‘Moreover, there are important mimicking disorders such as migraine with aura, seizures, metabolic and toxic disorders, peripheral vestibular disease, Bell’s palsy, collapse, and functional disorders.(1–3)’

2. Study design, Line 105 - "cross-sectional study". As per the methodology discussed in the manuscript, this would qualify as a retrospective cross-sectional study specifically. Please correct.

Answer:

Thank you for noticing that the manuscript does not mention the retrospective nature of the data collection.

Changes to the manuscript:

- We have changed the wording in the methods to: ‘This is a cross-sectional study using retrospective data from telephone triage tape-recordings of patients calling to the OHS-PC.’

- We have changed the wording in the abstract to: ‘This is a cross-sectional study of retrospectively gathered routine care data from telephone triage tape-recordings of patients calling the OHS-PC with neurological deficit symptoms, classified as BEFAST positive.’

3. Outcome, Line 134 - "The primary outcome of this study was a final diagnosis of stroke or TIA diagnosed by a neurologist or GP." Can the authors provide more details on how the diagnosis of stroke/TIA was established? Was it based on clinical symptoms, neuroimaging or both? Please modify as appropriate.

In the 83% referred to the neurologist, the diagnosis was based on clinical symptoms plus neuroimaging, thus following the full diagnostic assessment of the treating neurologist. The diagnosis in the other 17% (mainly older patients), was based on the GP’s assessment of clinical symptoms.

Changes to the manuscript

- We changed this sentence in the Methods to: ‘The primary outcome of this study was a final diagnosis of stroke or TIA diagnosed by a neurologist or GP, the first with neuroimaging and the latter based on neurological deficit symptoms only.’

- We changed the last sentence of the paragraph describing the patient characteristics in the Results to: ‘A neurologist diagnosed stroke or TIA in 83% of the cases based on clinical symptoms plus neuroimaging, and 17% (mainly older patients) was diagnosed by GPs based on clinical symptoms.’

4. Results, line 207 - "35% TIA or minor stroke." How many of these were moderate or high risk TIA? Please include in the results.

Answer:

Unfortunately, this information was not available in the routine care data. TIA and minor stroke were considered and presented as a single variable during data collection and writing.

5. Discussion, Line 281 - " By design, we selected patients that were all classified as BEFAST positive in our study sample, therefore, it was not feasible to calculate sensitivity and specificity for the BEFAST triaging tool." It would have been more useful to see the sensitivity and specificity of BE-FAST in this patient population and to draw a meaningful conclusion on the performance of BE-FAST scale as compared to some of the other numbers in prior literature. The authors had access to all the records of stroke/TIA diagnosis to begin with. Any particular reason as to why only BE-FAST positive patients were selected for this study which probably limited the ability to calculate sensitivity, specificity, PPV and NPV in this patient population? Please explain in the discussion or limitations subheading.

Answer:

This is a valid question and in the initial design of our study, we did plan to evaluate the sensitivity, specificity, PPV and NPV of the BEFAST tool for telephone triage in out-of-hours primary care (OHS-PC). However, none of the included patients suspected of stroke or TIA (based on International Classification of Primary Care (ICPC) codes and/or keywords in the electronic healthcare records (EHR) of the OHS-PCs) in our random sample of callers were classified as BEFAST negative. All had at least one BEFAST positive variable (balance disturbance, eye symptoms, face drooping, arm symptoms, speech problems).

To be more precise (see also the population section of our results), the initial dataset contained 1,381 patients suspected of stroke or TIA based on our inclusion criteria. 1,289 (93%) of these patients were considered BEFAST positive based on the presence of one or more symptoms. 92 (7%) of these patients had at least one missing variable on BEFAST and all other symptoms scored absent. However, because all variables should be negative to classify an individual as BEFAST negative and because we refrained from imputation of BEFAST variables due to data complexity (as explained in the methods section), eventually no included patients could be classified as BEFAST negative. Likely, this is also a consequence of the setting where we recruited patients, namely patients calling the OHS-PC service for complaints that lead to a suspicion of TIA/stroke, in fact because they experienced ‘BEFAST symptoms’. Put simply, patients without ‘BEFAST symptoms’ simply did not call the OHS-PC service and thus were not included in our dataset.

For this reason, we did not have a ‘test (in this case BEFAST) negative’ group to calculate sensitivity, specificity, PPV and NPV for BEFAST in this setting. In our paper, we, therefore, focus on exploring the risk of stroke or TIA in BEFAST-positive callers as this is the patient group that is calling OHS-PC for subsequent advice and/or management. Subsequently, our aim was to improve urgency allocation and efficiency of telephone triage in the out-of-hours primary care setting by exploring additional variables that could be further used to differentiate between high- and low-risk patients for having TIA/stroke. We found that the risk of stroke or TIA diagnosis was high (52%) among 1,289 BEFAST positive patients and that only the addition of age and sex improved predicting stroke or TIA in this group.

Changes to the manuscript:

We added the following sentence about sensitivity, specificity, NPV and PPV to the limitations section: ‘Importantly, BEFAST is only considered negative if none of the symptoms are present, which was in none of our patients (partly due to missing data). As a result, we could not calculate the sensitivity, specificity, and predictive values of BE-FAST.’

6. Conclusion - " The addition of age and sex can improve risk stratification with higher risks observed in older and male patients." The median age noted was almost similar between the low urgency and high urgency group (80 vs. 79 years). Yet, age was noted to be a significant predictor of stroke/TIA in BE-FAST positive patients. Please explain?

Answer:

The reviewer refers to the median ages of patients of the specific groups correctly classified as ‘high urgency’ or incorrectly as ‘low urgency’ in the group of patients with the outcome present (diagnosis of stroke or TIA, n=672). These groups do not differ in median age. In the main analysis, the median age of patients with and without the outcome (n=1,289) is used as a predictor, which differed substantially (median age 79 years in those with TIA/stroke versus 64 years in those without TIA/stroke, respectively).

It should also be noted that the numbers provided in the baseline table reflect ‘univariable’ associations between variables and the outcome stroke or TIA. These associations may differ from the associations in the context of other variables as is investigated through multivariable analysis including interaction terms and spline functions.

7. The authors did not discuss if addition of age and sex to BE-FAST based on the results of this single center study would be applicable to patients from another geographic location - South East Asia (higher prevalence of elderly population in general along with vascular risk factors, African American and hispanic population (earlier age of onset of stroke and higher prevalence of atherosclerosis)? Please discuss under implications of this study.

Answer:

We agree that based on our research, the generalizability to other settings in which predictor and outcome prevalence differ, such as in another geographic region, cannot be confirmed. Therefore, in the strengths and limitations section we state: ‘Formal external validation of the final prediction model should be conducted to confirm predictive performance over time in the Dutch OHS-PC setting or to prove its predictive performance in other settings.’

Changes to the manuscript:

To the Clinical implications this sentence was added: ‘External validation studies (temporal as well as geographical) and implementation studies are needed to evaluate the generalizability and clinical impact of these findings.’

Attachment

Submitted filename: Rebuttal_final.docx

pone.0310769.s005.docx (30.7KB, docx)

Decision Letter 1

Shashank Shekhar

6 Sep 2024

Additional predictors of stroke and transient ischaemic attack in BEFAST positive patients in out-of-hours emergency primary care

PONE-D-23-43803R1

Dear Dr. van Royen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shashank Shekhar, MD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Very useful tool for clinicians to stratify patients at risk for stroke. It shall be broadly. disseminated

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Aurel Popa-Wagner

Reviewer #2: No

**********

Acceptance letter

Shashank Shekhar

11 Sep 2024

PONE-D-23-43803R1

PLOS ONE

Dear Dr. van Royen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shashank Shekhar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Patient flow through the study.

    (TIF)

    pone.0310769.s001.tif (439.5KB, tif)
    S1 Table. ICPC codes, keywords and definition of BEFAST items used in this study.

    ICPC = International Classification of Primary Care.

    (DOCX)

    pone.0310769.s002.docx (13.5KB, docx)
    S2 Table. Percentage of missing data per predictor in BEFAST positive patients.

    (DOCX)

    pone.0310769.s003.docx (13.8KB, docx)
    S3 Table. Model development and apparent performance of model 2, model 3 and model 4 using multivariable logistic regression.

    Regression coefficients with 95% confidence intervals, c-statistic, and apparent performance measures of model 2, model 3 and model 4. Age was divided into three subgroups (shown as age, age’ and age”) using restricted cubic spline function to account for non-linearity. *The predictor history of cardio- and cerebrovascular disease is a combination of history of stroke, history of TIA and history of cardiovascular disease. **The predictor cardiovascular risk factors is a combination of diabetes, hypercholesterolaemia and hypertension. CI = confidence interval.

    (DOCX)

    pone.0310769.s004.docx (16KB, docx)
    Attachment

    Submitted filename: Rebuttal_final.docx

    pone.0310769.s005.docx (30.7KB, docx)

    Data Availability Statement

    Data cannot be shared publicly because there are ethical restrictions being placed upon the data. The data contain potentially identifying and sensitive patient information. Moreover, a third party was involved in providing the telephone triage recordings from which the data were collected. This third party did not agree to make the data publicly available. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. The data can also be requested by filling in the data request form from the University Medical Center Utrecht. The link is provided below. Research support staff from the division will review and consider the requests. https://preview.umcutrecht.nl/en/data-request-form-umc-utrecht.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES